During stenting of a 90% occluded lesion in the superficial femoral artery with heavy calcification and vessel tortuosity, a smart control stent could not cross the lesion.It was removed and the outer sheath was frayed.The stent was changed to another stent to finish the procedure successfully.There was no reported patient injury.The device will not be returned for analysis.The product appeared normal when opened in the packaging.The product was stored, handled, inspected and prepped according to the instructions for use.There was nothing unusual noted about the stent delivery system prior to use.Additional details such as difficulty removing the device from the vessel or the sheath or guiding catheter, if any excessive force was needed for removal or resistance met during delivery system withdrawal.The brand and size of sheath and guiding catheter used in the procedure are also unknown.
|
The site reported that they were unable to cross a target lesion with a 6 x 40mm smart control stent delivery system (sds).When removed, they noted that the outer sheath was frayed.The procedure was successfully completed with another device with no reported patient injury.The event involved a target lesion located in the superficial femoral artery that was described as 90% stenosed, heavily calcified and tortuous.The site reported that the device had been stored, handled, inspected and prepped according to the instructions for use (ifu).The sds appeared normal when it was removed from its packaging and there was nothing unusual noted about the sds prior to use.The smart control sds was advanced through the patient¿s vasculature but failed to cross the lesion.It was removed without difficulty but the site noted that the outer sheath was frayed.The product was not returned for evaluation.A review of the manufacturing records for this lot of products revealed that it met specification prior to release.Without the return of the device for analysis, the reported event could not be confirmed and no determination of possible contributing factors could be made.According to the product ifu, this device is indicated for improving luminal diameter in patients with symptomatic atherosclerotic disease of the common and/or external iliac arteries up to 126mm in length, with a reference vessel diameter of 4 to 9mm and angiographic evidence of a patent profunda or superficial femoral artery.The safety and effectiveness of using this device has not been demonstrated in patients with lesions that are either totally or densely calcified.Based on the information available for review, there are vessel characteristics (heavily calcified and tortuous) that may have contributed to the reported event.Based on the device history record review, there is no indication that the event is related to the device manufacturing process.Therefore, no corrective actions will be taken at this time.
|